Compare TITN & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TITN | ZVRA |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.5M | 664.7M |
| IPO Year | 2007 | 2015 |
| Metric | TITN | ZVRA |
|---|---|---|
| Price | $21.93 | $9.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $25.25 | $23.00 |
| AVG Volume (30 Days) | 127.7K | ★ 973.9K |
| Earning Date | 11-24-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $2,427,107,000.00 | $106,470,000.00 |
| Revenue This Year | N/A | $43.81 |
| Revenue Next Year | $3.29 | $15.30 |
| P/E Ratio | ★ N/A | $8.87 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $13.21 | $8.01 |
| 52 Week High | $26.90 | $15.04 |
| Indicator | TITN | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 38.37 |
| Support Level | $19.42 | $8.62 |
| Resistance Level | $21.84 | $9.24 |
| Average True Range (ATR) | 1.25 | 0.65 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 34.06 | 8.38 |
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.